Analysis of gout remission definitions in a randomised controlled trial of colchicine prophylaxis for people with gout initiating allopurinol

Gout

Colchicine concentrations and relationship with colchicine efficacy and adverse events; post-hoc analysis of a randomised clinical trial of colchicine for gout flare prophylaxis

Arthritis Care Res (Hoboken)

Stamp LK, Horne A, Mihov B, Drake J, Haslett J, Chapman P, Wright DF, Frampton C, Dalbeth N

doi: 10.1002/acr.25548

Gout

Comparative Cardiovascular Safety of NSAID versus Colchicine Use When Initiating Urate-Lowering Therapy Among Patients with Gout: Target Trial Emulations

Arthritis Rheumatol

Yokose C, McCormick N, Lu N, Jiang B, Tan K, Chigurupati S, Rai S, Challener G, Aviña-Zubieta JA, Cipolletta E, Abhishek A, Gaffo A, Januzzi JL, Zhang Y, Choi HK

doi: 10.1002/art.43259

Osteoarthritis

Tailored exercise management versus usual care for people aged 80 years or older with hip/knee osteoarthritis and comorbidities (TEMPO): multicentre feasibility randomised controlled trial in England

BMJ Open

Nicolson PJA, Holden MA, Marian I, Saeedi E, Williamson E, Moylan D, Stone M, Hopewell S, Lamb SE, TEMPO feasibility trial collaborators

doi: 10.1136/bmjopen-2025-104813

Rheumatoid Arthritis

Remote monitoring or patient-initiated care in axial spondyloarthritis: a 3-armed randomised controlled noninferiority trial

Ann Rheum Dis

Berg IJ, Kristianslund EK, Tveter AT, Sexton J, Bakland G, Gossec L, Hakim S, Macfarlane GJ, Moholt E, Provan SA, Thomassen EEK, de Thurah A, Haavardsholm EA, Lillegraven S, Osteras N

doi: 10.1016/j.ard.2025.04.019

Further Publications Dermatology

Post-exposure prophylaxis regimen of rabies monoclonal antibody and vaccine in category 3 potential exposure patients: a phase 4, open-label, randomised, active-controlled trial

Lancet

Kulkarni PS, Potey AV, Kapse D, Bhamare C, Gawande A, Munshi R, Pawar S, Gogtay NJ, Agarwal A, Tambe M, Thakre S, Samuel CJ, Khan SMS, S RH, Rana D, Singh N, Kamath V, Bhalla HL, Poonawalla CS, Mani RS, Gunale B, RAB-04 study group

doi: 10.1016/S0140-6736(25)00735-4

Gout

The Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) definition of clinical remission in gout

Ann Rheum Dis

Tabi-Amponsah AD, Stewart S, Stamp LK, Taylor WJ, Terkeltaub R, Dalbeth N

doi: 10.1016/j.ard.2025.05.017

Systemic Lupus Erythematosus

LLDAS and remission attainment with anifrolumab treatment in patients with systemic lupus erythematosus: results from the TULIP and long-term extension randomised controlled trials

Ann Rheum Dis

Morand EF, van Vollenhoven R, Furie RA, Kalunian KC, Manzi S, Abreu G, Tummala R, Duncan EA, Al-Mossawi H, Lindholm C

doi: 10.1016/j.ard.2025.01.016

Further Publications Dermatology

Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial

Lancet

Tang JY, Marinkovich MP, Wiss K, McCarthy D, Truesdale A, Chiou AS, Eid E, McIntyre JK, Bailey I, Furukawa LK, Gorell ES, Harris N, Khosla RK, Peter Lorenz H, Lu Y, Nazaroff J, Grachev ID, Moore AJ

doi: 10.1016/S0140-6736(25)00778-0

Osteoarthritis

Vascular occlusion for optimising the functional improvement in patients with knee osteoarthritis: a randomised controlled trial

Ann Rheum Dis

Jacobs E, Stroobant L, Victor J, Elewaut D, Tampere T, Wallaert S, Witvrouw E, Schuermans J, Wezenbeek E

doi: 10.1136/ard-2024-226579

Related content

Colchicine concentrations and relationship with colchicine efficacy and adverse events; post-hoc analysis of a randomised clinical trial of colchicine for gout flare prophylaxis

Comparative Cardiovascular Safety of NSAID versus Colchicine Use When Initiating Urate-Lowering Therapy Among Patients with Gout: Target Trial Emulations

Tailored exercise management versus usual care for people aged 80 years or older with hip/knee osteoarthritis and comorbidities (TEMPO): multicentre feasibility randomised controlled trial in England

Remote monitoring or patient-initiated care in axial spondyloarthritis: a 3-armed randomised controlled noninferiority trial

Post-exposure prophylaxis regimen of rabies monoclonal antibody and vaccine in category 3 potential exposure patients: a phase 4, open-label, randomised, active-controlled trial

The Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) definition of clinical remission in gout

LLDAS and remission attainment with anifrolumab treatment in patients with systemic lupus erythematosus: results from the TULIP and long-term extension randomised controlled trials

Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial

Vascular occlusion for optimising the functional improvement in patients with knee osteoarthritis: a randomised controlled trial